SynopsisCommon scar treatment products are products that improve the physical, biological, chemical and other factors of the human skin and soft tissues through the way of drugs, resulting in serious damage to the skin and soft tissues and cannot be repaired normally......
SynopsisThe global Lacrimal Apparatus Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Lacrimal Apparatus Device is estimated t.....
SynopsisThe global Bariatric Surgeries market was valued at US$ 1660.5 million in 2023 and is anticipated to reach US$ 2611 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030. According to our research, the global market for medical .....
SynopsisThe global Tenofovir & Emtricitabine Combination Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion .....
SynopsisThe global Medical Hot Melt Adhesive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices i.....
SynopsisThe global Absorbable Surgical Suture market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global market for medical devices is estimated at US$ 603 bil.....
SynopsisNuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molec.....
SynopsisThe global Botulinum Toxin Injections market size is expected to reach US$ 1149.5 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Botulinum Toxin Injections in various end use industr.....
SynopsisRECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A. The global Recombinant Factor VIII market size is expected to reach US$ 2310.5 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The mar.....
SynopsisThe global Congenital Heart Disease Occluder market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Congenital Heart Disease Occlude.....
